Terminated NA INTERVENTIONAL 2-arm NCT02653495

Impact of Metabolic Syndrome on Flu Vaccine Efficacy

Sponsor: Rockefeller University

Conditions Immune Deficiency Metabolic Syndrome

Updated 9 times since 2017 Last updated: Sep 1, 2017 Started: Jan 31, 2016 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Target accrual not met

Other terminated trials from Rockefeller University

See all terminations from Rockefeller University

A NA clinical study on Immune Deficiency and Metabolic Syndrome, this trial is terminated or withdrawn. The trial is conducted by Rockefeller University and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Dec 2021 — Jul 2024 [monthly]

Terminated NA
Jan 2021 — Dec 2021 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA

▶ Show 4 earlier versions

Oct 2017 — Jun 2018 [monthly]

Terminated NA
May 2017 — Oct 2017 [monthly]

Terminated NA

Status: Recruiting → Terminated
Feb 2017 — May 2017 [monthly]

Recruiting NA

Status: Active Not Recruiting → Recruiting
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rockefeller University

Data source: Rockefeller University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States